These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7813597)

  • 21. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
    Reimers JI
    Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic strategies for Type 1 and Type 2 diabetes mellitus.
    Giannoukakis N; Pietropaolo M; Trucco M
    Diabetes Nutr Metab; 2002 Jun; 15(3):173-203. PubMed ID: 12173733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet cell transplantation as a cure for insulin dependent diabetes: current improvements in preserving islet cell mass and function.
    Fontaine MJ; Fan W
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):170-9. PubMed ID: 14599964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale, effects, toxicology and clinical experiences. ENDIT Group].
    Reimers JI; Andersen HU; Pociot F
    Ugeskr Laeger; 1994 Jan; 156(4):461-5. PubMed ID: 8140661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms of beta-cell destruction in IDDM: the role of nicotinamide.
    Gale EA
    Horm Res; 1996; 45 Suppl 1():39-43. PubMed ID: 8805029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-cell replacement in immunosuppressed recipients: old and new clinical indications.
    Bertuzzi F; Ricordi C
    Acta Diabetol; 2007 Dec; 44(4):171-6. PubMed ID: 17924054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation, transplantation, and functional studies of adult porcine islets of Langerhans.
    Nielsen TB; Yderstraede KB; Beck-Nielsen H
    Comp Med; 2002 Apr; 52(2):127-35. PubMed ID: 12022392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Islet regeneration needed for overcoming autoimmune destruction - considerations on the pathogenesis of type 1 diabetes.
    von Herrath M; Homann D
    Pediatr Diabetes; 2004; 5 Suppl 2():23-8. PubMed ID: 15601371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early intervention in insulin-dependent diabetes mellitus.
    Cahill GF
    Curr Probl Clin Biochem; 1983; 12():108-18. PubMed ID: 6418442
    [No Abstract]   [Full Text] [Related]  

  • 31. [Does the current knowledge on the pathogenesis of type 1 diabetes justify immunotherapeutic intervention?].
    Pozzilli P; Signore A; Andreani D
    Recenti Prog Med; 1986 May; 77(5):245-8. PubMed ID: 3526461
    [No Abstract]   [Full Text] [Related]  

  • 32. Current and future perspective in the management of diabetes.
    Vishwanathan V
    J Indian Med Assoc; 2002 Mar; 100(3):181-3. PubMed ID: 12408280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy for the prevention and treatment of type 1 diabetes.
    Goudy KS; Tisch R
    Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotinamide: potential for the prevention of type 1 diabetes?
    Gale EA
    Horm Metab Res; 1996 Jul; 28(7):361-4. PubMed ID: 8858387
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical review 17: Immunotherapy of type I diabetes mellitus.
    Marks JB; Skyler JS
    J Clin Endocrinol Metab; 1991 Jan; 72(1):3-9. PubMed ID: 1986025
    [No Abstract]   [Full Text] [Related]  

  • 36. Type I diabetes. Foreword.
    LeRoith D
    Endocrinol Metab Clin North Am; 2010 Sep; 39(3):xiii-xv. PubMed ID: 20723813
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunotherapy in type 1 diabetes.
    Pozzilli P
    Diabet Med; 1988 Nov; 5(8):734-8. PubMed ID: 2975564
    [No Abstract]   [Full Text] [Related]  

  • 38. Current world literature.
    Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):177-85. PubMed ID: 20190584
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy in type 1 diabetes: present status.
    Pozzilli P; Kolb H
    Immunol Today; 1989 Oct; 10(10):321-2. PubMed ID: 2679628
    [No Abstract]   [Full Text] [Related]  

  • 40. New trends in diabetes research: the search for an etiologically oriented treatment for type I diabetes mellitus.
    Eizirik DL; Migliorini RH
    Braz J Med Biol Res; 1983 Dec; 16(4):381-3. PubMed ID: 6201223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.